How the Body Switches Between Fuel Sources: Glucose, Glycogen, Fatty Acids, Lactate, Ketones, and Amino Acids

The body does not use one exclusive fuel at a time. Glucose, glycogen, fatty acids, lactate, ketone bodies, and selected amino-acid-derived molecules can all contribute to metabolism, often simultaneously. Their relative contributions change as nutrient availability, physical activity, hormone signaling, tissue demand, oxygen availability, glycogen stores, sleep, illness, and other conditions change.

This article explains fuel switching through glucose oxidation, glycogen storage and breakdown, fatty-acid mobilisation, beta-oxidation, lactate transport, ketone metabolism, amino-acid use, insulin, glucagon, catecholamines, cortisol, physical activity, feeding, fasting, tissue differences, respiratory measurements, metabolic flexibility, and evidence limitations.

InStrips products are offered for research and analytical use only. Human consumption and medical application fall outside this product context. Information about fuel switching, fat oxidation, glucose metabolism, fasting, ketones, insulin signaling, exercise, blood concentration, or research compounds does not establish safety, effectiveness, dosage, weight loss, diabetes treatment, performance improvement, metabolic correction, or suitability for human use.

What Fuel Switching Means

Fuel switching describes changes in the relative contribution of different energy substrates to ATP production and other metabolic processes.

The body may draw from:

• recently absorbed glucose
• liver glycogen
• muscle glycogen
• circulating fatty acids
• fat stored within tissues
• lactate
• ketone bodies
• selected amino-acid-derived molecules

The body generally uses a mixture rather than moving between completely isolated metabolic states.

Fuel Switching Is Continuous

Fuel use changes from moment to moment.

It may shift with:

• time since the previous meal
• meal composition
• physical-activity intensity
• activity duration
• sleep
• stress
• temperature
• illness
• medications
• training status
• glycogen availability

Fuel Use Is Not an On-Off System

Common Simplification	More Accurate Interpretation
The body burns sugar or fat	Carbohydrate and fat usually contribute together in changing proportions
Insulin turns fat burning off completely	Insulin generally reduces fatty-acid release, but fat metabolism does not disappear
Fasting means only fat is used	Glucose, fatty acids, lactate, ketones, and amino-acid-derived substrates may all contribute
High-intensity exercise uses no fat	Carbohydrate contribution rises, but oxidative fat metabolism may still continue
Using more fat means losing more body fat	Acute fat oxidation and long-term adipose-tissue change are different

ATP Is the Immediate Energy Currency

Adenosine triphosphate, commonly abbreviated as ATP, transfers usable energy for:

• muscle contraction
• nerve signaling
• ion transport
• protein synthesis
• cellular maintenance
• biosynthetic reactions

Carbohydrate, fat, lactate, ketones, and amino-acid-derived substrates contribute indirectly by supporting ATP regeneration.

Stored ATP Is Limited

Cells contain only a limited amount of immediately available ATP.

ATP must therefore be regenerated continuously through pathways involving:

• phosphocreatine
• glycolysis
• the citric acid cycle
• oxidative phosphorylation
• substrate-level phosphorylation

The Main Fuel Categories

Metabolic fuels can be grouped broadly into:

• carbohydrate-derived substrates
• fat-derived substrates
• lactate
• ketone bodies
• amino-acid-derived substrates

Each enters energy metabolism through different pathways.

Glucose

Glucose may come from:

• digested carbohydrate
• liver glycogen
• gluconeogenesis

Glucose can support:

• glycolysis
• ATP production
• glycogen storage
• biosynthetic pathways
• brain and nervous-system metabolism

Glycolysis

Glycolysis converts glucose-related molecules into pyruvate.

This pathway produces:

• ATP
• reduced electron carriers
• pyruvate

Glycolysis can operate rapidly and is especially important when ATP demand rises quickly.

Pyruvate

Pyruvate may:

• enter mitochondria
• be converted into acetyl-CoA
• enter the citric acid cycle
• be converted into lactate
• participate in other metabolic pathways

Glucose Oxidation

Complete oxidation of glucose-derived substrates involves:

• glycolysis
• pyruvate processing
• the citric acid cycle
• the electron-transport system
• oxidative phosphorylation

Glycogen

Glycogen is stored carbohydrate found mainly in:

• skeletal muscle
• the liver

These stores have different physiological roles.

Muscle Glycogen

Muscle glycogen is used primarily within the muscle where it is stored.

Its use may depend on:

• exercise intensity
• exercise duration
• muscle-fibre recruitment
• training status
• starting glycogen concentration
• temperature

Liver Glycogen

Liver glycogen can contribute to circulating glucose between meals, overnight, and during physical activity.

The liver helps maintain glucose availability for tissues that depend substantially on circulating glucose.

Glycogenolysis

Glycogenolysis breaks glycogen into glucose-related molecules.

It may be stimulated by:

• muscle contraction
• glucagon-related signaling in the liver
• catecholamines
• cellular energy demand

Glycogenesis

Glycogenesis is the formation of glycogen from glucose-related molecules.

It may occur when:

• glucose is available
• glycogen stores have capacity
• insulin-related signaling is present
• relevant enzymes are active

Glycogen Storage Has Limited Capacity

Compared with adipose-tissue energy storage, glycogen stores are relatively limited.

They can nevertheless support:

• rapid energy demand
• exercise
• between-meal glucose regulation
• overnight metabolism

Fatty Acids

Fatty acids may come from:

• dietary fat
• adipose-tissue triglycerides
• fat stored within or near muscle cells
• circulating lipoproteins

Triglycerides

Triglycerides contain fatty acids attached to glycerol.

They are stored mainly in adipose tissue but may also be found in:

• skeletal muscle
• the liver
• circulating lipoproteins
• other tissues

Lipolysis

Lipolysis breaks triglycerides into:

• fatty acids
• glycerol

Fatty acids may be released into circulation or used locally.

Lipolysis Does Not Equal Fat Loss

Released fatty acids may be:

• oxidised
• taken up by another tissue
• returned to storage
• used in membrane synthesis
• used in signaling pathways

Fatty-Acid Uptake

Before oxidation, fatty acids may need to:

• travel through blood
• associate with carrier proteins
• cross cell membranes
• be activated chemically
• reach mitochondria

Beta-Oxidation

Beta-oxidation breaks fatty acids into acetyl-CoA-related units.

These can enter:

• the citric acid cycle
• ketone-related pathways in the liver
• other metabolic processes

Fat Oxidation Requires Several Steps

Fatty-acid mobilisation alone does not prove oxidation.

Meaningful oxidation requires:

• release or local availability
• transport
• cellular uptake
• mitochondrial access
• beta-oxidation
• citric-acid-cycle activity
• electron transport

Lactate as a Fuel

Lactate is a normal metabolic intermediate.

It may be produced when glycolytic activity increases and may then be:

• oxidised by active muscle
• oxidised by less-active muscle
• used by the heart
• transported to the liver
• used in glucose-related pathways
• involved in cellular signaling

The Lactate Shuttle

The lactate-shuttle concept describes movement of lactate between:

• cells
• muscle fibres
• organs
• blood and tissues

Lactate produced in one location can be used as a fuel or precursor in another.

Lactate Is Not Simply Waste

Lactate production does not mean:

• oxygen is completely absent
• metabolism has failed
• muscle soreness will occur later
• the compound cannot be reused

Ketone Bodies

Ketone bodies are produced mainly by the liver from fatty-acid-derived acetyl-CoA under selected metabolic conditions.

The main ketone bodies include:

• acetoacetate
• beta-hydroxybutyrate
• acetone

When Ketone Production May Increase

Ketone production may become more prominent during:

• prolonged fasting
• very low carbohydrate availability
• extended exercise
• selected metabolic conditions
• uncontrolled insulin deficiency

Ketosis and Ketoacidosis Are Different

Ketosis describes increased ketone production and use under selected physiological conditions.

Ketoacidosis is a dangerous metabolic state involving excessive ketone accumulation and acid-base disturbance.

These should not be treated as interchangeable concepts.

Ketone Use

Ketone bodies may be used by tissues including:

• skeletal muscle
• the heart
• the kidneys
• the brain under selected conditions

The liver produces ketones but does not use them in the same manner as many peripheral tissues.

Ketones Do Not Replace Glucose Completely

Even during prolonged fasting or low-carbohydrate intake, some tissues and pathways continue to require glucose or glucose-derived molecules.

Amino Acids

Amino acids are used primarily for:

• protein synthesis
• enzyme production
• transport proteins
• signaling molecules
• nitrogen-containing compounds
• tissue maintenance

They can also contribute to energy metabolism under selected conditions.

Amino-Acid Catabolism

Amino-acid breakdown may involve:

• removal or transfer of nitrogen
• entry of carbon skeletons into metabolic pathways
• urea formation
• gluconeogenesis
• oxidation

Protein Is Not a Dedicated Energy Store

Body proteins have structural and functional roles.

Using amino acids for energy may occur during:

• prolonged exercise
• fasting
• energy deficiency
• illness
• high protein turnover

Gluconeogenesis

Gluconeogenesis produces glucose from non-carbohydrate precursors.

Possible precursors include:

• lactate
• glycerol
• selected amino-acid-derived molecules

Gluconeogenesis Does Not Mean Glucose Is Created From Nothing

It rearranges carbon-containing molecules into glucose-related forms.

The process requires energy and appropriate substrates.

What Changes After Eating

After a meal, recently absorbed nutrients become more available.

Depending on the meal, circulation may receive:

• glucose
• amino acids
• fatty acids and lipoprotein-related particles
• vitamins
• minerals

The Fed State

The fed state commonly involves:

• greater use of incoming nutrients
• glycogen formation
• protein synthesis
• fat storage
• reduced release of selected stored fuels

This is a gradual shift rather than an instant metabolic switch.

Insulin After Food Intake

Insulin-related signaling may increase in response to:

• blood glucose
• selected amino acids
• digestive-hormone signals
• meal-related nervous-system activity

Insulin and Fuel Selection

Insulin may influence:

• glucose uptake
• glycogen formation
• liver glucose output
• fatty-acid release
• triglyceride storage
• protein-related signaling

Insulin Does Not Stop All Fat Metabolism

Even after a meal:

• fat may be absorbed from food
• fatty acids may circulate
• some tissues may continue oxidising fat
• stored fat turnover may continue at a reduced rate

Meal Composition Matters

A meal’s metabolic effects may vary with:

• carbohydrate amount
• fat amount
• protein amount
• fibre
• food structure
• meal size
• gastric emptying
• recent activity

What Changes Between Meals

As recently absorbed nutrients decline, the body relies more heavily on stored energy.

This may involve:

• liver glycogen breakdown
• gluconeogenesis
• fatty-acid release
• greater relative fat oxidation
• continued glucose use by selected tissues

The Post-Absorptive State

The post-absorptive state generally refers to the period after nutrients from a meal are no longer entering circulation at their earlier rate.

This does not mean that digestion or absorption has completely stopped.

Overnight Fuel Use

During ordinary overnight fasting, metabolism may involve:

• liver glycogen use
• fatty-acid release
• fatty-acid oxidation
• gluconeogenesis
• continued glucose use by the brain and other tissues

Overnight Fasting Is Not the Same as Prolonged Fasting

The longer food is unavailable, the more substantially metabolic pathways may shift.

However, timing and magnitude vary with:

• starting glycogen stores
• recent meals
• physical activity
• body composition
• health
• medications

Prolonged Fasting

During longer fasting conditions, the body may rely more heavily on:

• fatty-acid mobilisation
• fatty-acid oxidation
• ketone production
• gluconeogenesis
• amino-acid-related substrates

Fasting Does Not Produce One Uniform Response

Responses may differ according to:

• fasting duration
• hydration
• medications
• pregnancy
• diabetes
• liver function
• kidney function
• physical activity
• starting nutritional state

Fasting Is Not Required for Normal Fuel Switching

The body adjusts fuel selection continually during ordinary meal intervals, sleep, physical activity, and rest.

Physical Activity

Physical activity increases ATP demand.

The fuel mixture used depends on:

• activity intensity
• activity duration
• muscle-fibre recruitment
• training status
• recent meals
• glycogen availability
• temperature
• health

Higher-Intensity Activity

Higher intensity commonly increases reliance on:

• phosphocreatine
• muscle glycogen
• glycolysis
• rapid carbohydrate oxidation

This occurs because ATP must be regenerated rapidly.

Lower-Intensity Activity

Lower-intensity activity may permit a greater relative contribution from:

• circulating fatty acids
• intramuscular triglycerides
• oxidative metabolism

Relative and Absolute Fat Use Are Different

A greater percentage of energy may come from fat at lower intensity while total energy use per minute remains lower than during harder activity.

Longer-Duration Activity

As activity continues, fuel use may change because of:

• glycogen use
• fatty-acid availability
• hormonal changes
• body temperature
• fluid loss
• fatigue
• food intake during activity

Training Status

Training may influence:

• mitochondrial content
• oxidative enzymes
• capillary supply
• glycogen storage
• fatty-acid transport
• movement efficiency

These adaptations can alter the fuel mixture used at a given workload.

Absolute and Relative Exercise Intensity

The same walking or cycling speed can represent:

• low intensity for one person
• moderate intensity for another
• high intensity for someone else

Fuel selection should therefore be interpreted relative to individual capacity.

Hormonal Regulation

Fuel selection is influenced by hormones including:

• insulin
• glucagon
• adrenaline
• noradrenaline
• cortisol
• growth hormone
• thyroid-related signals

Glucagon

Glucagon contributes to liver fuel regulation, particularly when recently absorbed nutrients are less available.

It may influence:

• liver glycogen breakdown
• gluconeogenesis
• amino-acid metabolism
• ketone-related pathways

Catecholamines

Adrenaline- and noradrenaline-related signaling may influence:

• glycogen breakdown
• lipolysis
• liver glucose output
• blood flow
• heart rate
• alertness

Cortisol

Cortisol may contribute to:

• glucose availability
• amino-acid availability
• fat mobilisation
• stress responses
• circadian metabolic regulation

Hormones Do Not Act Alone

Fuel use also depends on:

• substrate availability
• cellular energy demand
• transporters
• enzyme activity
• blood flow
• oxygen delivery
• mitochondrial capacity

Tissue-Specific Fuel Use

Different tissues use fuels differently because they have different functions, enzymes, transporters, and metabolic capacities.

The Brain

The brain relies substantially on glucose under ordinary conditions.

During prolonged fasting or sustained ketosis, ketone bodies may contribute more to brain metabolism.

Some glucose requirement remains.

Skeletal Muscle

Skeletal muscle may use:

• glucose
• muscle glycogen
• fatty acids
• lactate
• ketone bodies under selected conditions
• selected amino-acid-derived substrates

The mixture changes with workload, fibre recruitment, training, and substrate availability.

The Heart

The heart can use several substrates, including:

• fatty acids
• glucose
• lactate
• ketone bodies

Fuel selection varies with workload, hormone signals, health, and substrate availability.

The Liver

The liver helps regulate whole-body fuel flow through:

• glycogen storage
• glycogen breakdown
• gluconeogenesis
• fatty-acid oxidation
• ketone production
• fat synthesis
• amino-acid metabolism

The Liver Produces but Does Not Substantially Use Ketones

Ketone bodies produced by the liver are exported for use by other tissues.

Adipose Tissue

Adipose tissue participates in:

• triglyceride storage
• fatty-acid release
• glucose uptake
• hormone production
• inflammatory signaling

Red Blood Cells

Red blood cells lack mitochondria.

They rely substantially on glycolysis and produce lactate.

The Kidneys

The kidneys contribute to:

• glucose handling
• gluconeogenesis under selected conditions
• fatty-acid use
• ketone use
• acid-base regulation
• elimination of metabolic products

Fuel Storage and Fuel Use Occur Together

Some tissues may be storing a nutrient while others are using it.

For example:

• the liver may form glycogen while another tissue oxidises glucose
• adipose tissue may store dietary fatty acids while muscle oxidises circulating fat
• lactate may be produced in one muscle fibre and oxidised in another

Whole-Body Measurements Can Hide Tissue Differences

A whole-body estimate cannot show fuel use in:

• each organ
• each muscle
• each muscle fibre
• each cellular compartment

Metabolic Flexibility

Metabolic flexibility broadly describes the ability to adjust fuel handling as nutrient availability and energy demand change.

It may involve:

• switching between fed and fasting conditions
• responding to exercise
• changing glucose oxidation
• changing fat oxidation
• responding to insulin
• adjusting liver glucose production

Fuel Switching and Metabolic Flexibility Are Related but Different

Fuel switching describes an observed change in fuel contribution.

Metabolic flexibility describes the broader capacity to make appropriate changes when conditions shift.

Metabolic Flexibility Is Not One Biomarker

It may be studied through:

• respiratory-exchange measurements
• meal challenges
• glucose-clamp studies
• exercise testing
• tracer studies
• blood-metabolite measurements

Metabolic Inflexibility

Metabolic inflexibility is a research concept describing an impaired or altered ability to adjust fuel use under defined experimental conditions.

It may be associated with:

• reduced insulin responsiveness
• mitochondrial changes
• low physical activity
• fat distribution
• illness
• sleep disruption
• medications

The Term Requires Context

A result depends on:

• the test used
• the starting metabolic state
• the tissue measured
• meal timing
• activity
• health

Sleep

Sleep interacts with fuel metabolism through:

• glucose regulation
• cortisol rhythms
• appetite
• physical activity
• sympathetic nervous-system activity
• meal timing

Overnight Metabolism Is Not Inactive

During sleep, the body continues:

• ATP production
• brain activity
• temperature regulation
• protein turnover
• liver glucose regulation
• fatty-acid metabolism

Stress

Stress may alter fuel availability through:

• catecholamines
• cortisol
• liver glucose output
• lipolysis
• sleep disruption
• changes in appetite

Acute and Persistent Stress Are Different

A short-term response may help mobilise energy for immediate demand.

Persistent stress may interact with sleep, activity, food intake, and metabolic regulation over time.

Ageing

Age-related factors that may affect fuel use include:

• muscle mass
• physical activity
• mitochondrial function
• body-fat distribution
• sleep
• medications
• hormonal changes

Age alone does not determine fuel selection.

Pregnancy

Pregnancy changes:

• insulin-related physiology
• placental hormone signaling
• glucose regulation
• fat metabolism
• energy requirements
• body composition

General information about fuel switching cannot determine appropriate fasting, food intake, glucose targets, medication use, or physical activity during pregnancy.

Diabetes and Fuel Use

Diabetes-related conditions may alter:

• insulin availability
• insulin responsiveness
• liver glucose output
• fatty-acid release
• ketone production
• urinary glucose loss
• medication effects

Fuel-Switching Information Should Not Guide Medication Changes

Glucose-lowering medicines, insulin, food intake, and activity can interact in ways requiring individual clinical planning.

Ketoacidosis Risk

Excessive ketone production can become dangerous under conditions such as severe insulin deficiency.

Symptoms requiring urgent assessment can include:

• persistent vomiting
• abdominal pain
• rapid or deep breathing
• marked thirst
• frequent urination
• confusion
• severe weakness
• reduced responsiveness

Liver Conditions

Liver conditions may affect:

• glycogen storage
• glucose production
• fatty-acid oxidation
• ketone production
• amino-acid metabolism
• hormone processing

Kidney Conditions

Kidney conditions may influence:

• glucose handling
• acid-base balance
• ketone clearance
• amino-acid metabolism
• medication clearance
• fluid balance

Thyroid-Related Conditions

Thyroid-related signaling may influence:

• energy turnover
• temperature regulation
• fat metabolism
• carbohydrate metabolism
• heart function
• protein turnover

Symptoms alone cannot establish a thyroid-related cause of altered energy or weight.

Medication Effects

Medicines may alter fuel metabolism through effects on:

• insulin secretion
• insulin responsiveness
• liver glucose output
• fatty-acid release
• appetite
• physical activity
• hormones
• kidney function

Fuel Switching and Body-Fat Loss

Using more fat during a particular hour does not independently determine whether adipose tissue decreases over days or months.

Long-term fat change depends on:

• fat storage
• fat mobilisation
• fat oxidation
• energy intake
• energy expenditure
• body composition
• time

Fat Burning Is an Incomplete Phrase

The phrase may refer to:

• lipolysis
• fatty-acid transport
• beta-oxidation
• whole-body fat oxidation
• body-fat loss

These are separate processes.

Carbohydrate Use Does Not Prevent Long-Term Fat Loss

Carbohydrate may contribute substantially during activity or after meals while longer-term adipose-tissue change still depends on overall storage and oxidation across time.

Ketones Do Not Prove Body-Fat Loss

Ketones may arise from:

• dietary conditions
• fasting
• exercise
• endogenous fat mobilisation
• exogenous ketone intake
• metabolic disease

A ketone measurement does not identify the complete source or long-term body-composition outcome.

How Fuel Use Is Measured

Researchers may use:

• indirect calorimetry
• respiratory-exchange measurements
• stable-isotope tracers
• blood metabolite testing
• muscle biopsy
• magnetic-resonance methods
• positron-emission methods
• metabolomics

Indirect Calorimetry

Indirect calorimetry estimates energy expenditure and fuel use through oxygen consumption and carbon-dioxide production.

Interpretation depends on:

• steady-state conditions
• ventilation
• recent food intake
• activity intensity
• acid-base changes
• equipment calibration

Respiratory Exchange Ratio

Respiratory exchange ratio compares carbon-dioxide production with oxygen consumption.

Under selected conditions, it can help estimate whole-body carbohydrate and fat contribution.

Respiratory Exchange Ratio Has Limits

It does not directly reveal:

• fuel use in each tissue
• local muscle glycogen use
• intracellular metabolic pathways
• long-term body-fat change
• protein contribution with complete precision

Stable-Isotope Tracers

Tracer methods may be used to study:

• glucose appearance
• glucose disappearance
• fatty-acid turnover
• lactate metabolism
• protein turnover
• ketone production

Results depend on sampling, modelling assumptions, isotope selection, and experimental design.

Blood Measurements

Researchers may measure:

• glucose
• insulin
• fatty acids
• glycerol
• lactate
• ketones
• amino acids

Blood Concentration Is Not the Same as Use

A substrate may be:

• entering blood
• leaving blood
• being produced
• being stored
• being oxidised
• being transported elsewhere

A single concentration cannot identify all of these rates.

Muscle Biopsy

A muscle biopsy may examine:

• glycogen
• lipid droplets
• enzymes
• transport proteins
• mitochondria
• gene expression

A sample from one muscle does not represent every muscle or whole-body metabolism.

Metabolomics

Metabolomics examines patterns of small molecules within a biological sample.

It may identify changes in:

• amino-acid-related metabolites
• fatty-acid-related molecules
• glucose-related pathways
• ketone-related compounds
• energy metabolism

Metabolite Patterns Do Not Prove Metabolic Flux

A concentration measurement does not always reveal how quickly a pathway is operating.

Common Misunderstandings

The Body Does Not Burn Only One Fuel at a Time

Several fuels commonly contribute simultaneously.

Fuel Switching Is Not Instantaneous

Changes usually occur gradually as hormones, substrates, tissues, and energy demand change.

Insulin Does Not Completely Stop Fat Metabolism

It can suppress fatty-acid release, but fat transport, storage, and oxidation may continue.

Fasting Does Not Mean the Body Uses Only Fat

Glucose, glycogen, gluconeogenesis, fatty acids, ketones, lactate, and amino-acid-derived substrates may all contribute.

Ketosis Is Not the Same as Ketoacidosis

They differ in cause, degree, acid-base effects, and clinical significance.

Lactate Is Not Metabolic Waste

It can be transported, oxidised, converted, and used in signaling.

Protein Is Not the Body’s Preferred Dedicated Fuel Store

Body proteins serve structural and functional roles, although amino acids can enter energy pathways.

High-Intensity Exercise Is Not Completely Anaerobic

Oxidative metabolism contributes even during intense activity.

Low-Intensity Exercise Does Not Use Only Fat

Carbohydrate and fat commonly contribute together.

Using More Fat During Exercise Does Not Guarantee Greater Fat Loss

Long-term adipose change depends on storage and oxidation across longer periods.

Carbohydrate Use Is Not Metabolic Failure

Carbohydrate supports rapid ATP demand and several essential tissues and pathways.

Feeling Tired Does Not Reveal Which Fuel Is Being Used

Fatigue may involve sleep, cardiovascular function, glycogen, temperature, illness, pain, motivation, or many other factors.

Feeling Hungry Does Not Prove Glycogen Is Empty

Hunger also reflects habits, food cues, sleep, stress, hormones, and social context.

A Ketone Reading Does Not Measure Fat Loss

Ketones do not reveal total daily energy balance or change in adipose tissue.

A Wearable Cannot Directly Measure Fuel Switching

Most wearables estimate movement, heart rate, or energy expenditure rather than tissue-specific substrate oxidation.

When Symptoms Require Prompt Medical Evaluation

Prompt assessment is appropriate for symptoms such as:

• confusion
• fainting
• seizures
• severe weakness
• rapid or deep breathing
• persistent vomiting
• severe dehydration
• chest pain
• marked drowsiness or reduced responsiveness
• an abrupt loss of function

When Persistent Metabolic Symptoms Deserve Clinical Review

Clinical review may be appropriate when fatigue, thirst, frequent urination, unexplained weight change, appetite change, reduced exercise tolerance, dizziness, or recurrent illness:

• persist
• worsen
• interfere with daily function
• occur during pregnancy
• follow a medication change
• occur with a known chronic condition

Peptides and Fuel-Metabolism Research

Peptides may act as hormones, signaling molecules, digestive signals, structural fragments, or experimental compounds.

Mechanistic or preclinical research may examine:

• glucose transport
• fatty-acid metabolism
• mitochondrial pathways
• insulin-related signaling
• appetite
• energy expenditure

These findings do not establish that a peptide product safely changes human fuel selection, causes fat loss, improves glucose control, or increases exercise performance.

BPC-157 Research Context

BPC-157 appears in selected laboratory and preclinical research discussions.

Research questions may involve:

• chemical identity
• stability
• metabolism
• blood detection
• tissue distribution
• cellular signaling
• analytical validity

Laboratory or animal findings do not establish human effects on fuel switching, fat oxidation, insulin sensitivity, body weight, exercise capacity, tissue healing, safety, dosing, or medical benefit.

TB-500 and Thymosin-Related Research

Thymosin-related compounds may be studied through:

• peptide stability
• proteolytic processing
• actin-related pathways
• cell movement
• tissue models
• fragment formation

Preclinical findings do not establish human effects on fuel use, metabolism, muscle preservation, recovery, fat loss, safety, or dosing.

NAD+ and Fuel Metabolism

NAD+ is an endogenous cofactor involved in:

• glycolysis
• the citric acid cycle
• oxidative phosphorylation
• fatty-acid oxidation
• amino-acid metabolism
• redox reactions
• NAD+-dependent signaling

Its central metabolic role does not establish that a specific NAD+ product:

• increases fat oxidation
• improves metabolic flexibility
• causes weight loss
• improves insulin sensitivity
• raises ATP production in a clinically meaningful way
• improves exercise performance

Combination Research Compounds

Combining research compounds may alter:

• absorption
• protein binding
• distribution
• metabolism
• clearance
• hormone signaling
• glucose regulation
• fatty-acid metabolism

Combination effects cannot be predicted by adding separate mechanistic claims.

Buccal Delivery

Buccal delivery places a formulation against the inner cheek.

Research may examine:

• film disintegration
• compound release
• saliva interaction
• mucosal permeability
• residence time
• swallowed fraction
• systemic exposure

Buccal Delivery Does Not Establish Fuel-Switching Effects

A delivery route does not prove:

• meaningful intact absorption
• liver exposure
• muscle exposure
• mitochondrial entry
• greater fat oxidation
• improved glucose handling
• weight loss
• metabolic flexibility

First-Pass Metabolism

A swallowed compound may undergo metabolism in the intestinal wall and liver before reaching broader circulation unchanged.

Buccal absorption may alter the initial pathway for the fraction crossing oral tissue, but it does not eliminate later metabolism or prove target-tissue exposure.

Absorption and Fuel-Switching Outcomes Are Different

Absorption describes movement across a biological barrier.

A fuel-switching effect requires separate evidence examining:

• intact systemic exposure
• tissue distribution
• cellular entry
• target engagement
• glucose oxidation
• fatty-acid oxidation
• ketone metabolism
• energy expenditure
• adverse effects

Blood Concentration and Mitochondrial Entry Are Different

A compound detected in blood does not necessarily reach:

• skeletal muscle
• the liver
• adipose tissue
• the brain
• cellular mitochondria
• specific metabolic enzymes
• the proposed molecular target

Mechanistic Evidence and Human Outcomes

Mechanistic research may identify changes in:

• AMPK-related signaling
• glucose transport
• fatty-acid oxidation
• ketone production
• mitochondrial markers
• gene expression
• enzyme activity

These findings do not independently establish:

• improved metabolic flexibility
• greater daily energy expenditure
• body-fat reduction
• better glucose control
• improved exercise performance
• safety
• product-specific effectiveness

Research-Use Context

Research-use compounds are best discussed through:

• verified chemical identity
• purity
• stability
• formulation
• absorption
• blood exposure
• tissue distribution
• metabolism
• target engagement
• fuel-oxidation measurements
• energy-expenditure measurements
• functional outcomes
• analytical validation
• evidence limitations

Fuel-related pathway findings should not be used to present a research compound as a fat-burning product, fasting aid, glucose-regulation treatment, ketogenic treatment, metabolic-flexibility product, exercise enhancer, or weight-management intervention.

Evidence Limits

Evidence may come from:

• cell cultures
• animal studies
• blood biomarkers
• indirect calorimetry
• stable-isotope tracers
• muscle biopsies
• exercise tests
• fasting studies
• controlled feeding studies
• short intervention trials

Strong interpretation requires attention to:

• feeding status
• fasting duration
• exercise intensity
• exercise duration
• training status
• health
• pregnancy
• medications
• sleep
• stress
• measurement method
• tissue studied
• study duration

Frequently Asked Questions

Does the body use only one fuel at a time?

No. It generally uses a mixture of carbohydrate, fat, lactate, ketones, and other substrates in changing proportions.

What does fuel switching mean?

It means that the relative contribution of different metabolic fuels changes as nutrient supply and energy demand change.

Is fuel switching the same as metabolic flexibility?

No. Fuel switching is the observed change, while metabolic flexibility is the broader ability to adjust appropriately across changing conditions.

What is the body’s preferred fuel?

There is no single universal preferred fuel. The mixture depends on tissue, activity, nutritional state, hormones, and substrate availability.

Why is glucose used more after meals?

Glucose availability and insulin-related signaling commonly rise, encouraging glucose use, glycogen formation, and other nutrient-handling pathways.

Does the body stop using fat after carbohydrate is eaten?

No. Fat metabolism continues, although fatty-acid release and relative oxidation may change.

Why does fat use increase between meals?

As recently absorbed nutrients decline, fatty acids released from storage may contribute more to the fuel mixture.

Does overnight fasting empty all glycogen stores?

No. The amount used depends on starting stores, activity, food intake, body size, and individual physiology.

Does fasting make the body use only fat?

No. Glucose, glycogen, gluconeogenesis, fatty acids, ketones, lactate, and amino-acid-derived substrates may all contribute.

Is fasting required for fat oxidation?

No. Fat oxidation occurs during ordinary feeding, fasting, rest, and physical activity.

Does longer fasting always produce more fat loss?

No. Fuel use during fasting does not alone determine long-term body-fat change, safety, or suitability.

What is glycogen?

Glycogen is stored carbohydrate located mainly in skeletal muscle and the liver.

What is the difference between muscle and liver glycogen?

Muscle glycogen is used mainly by the muscle where it is stored, while liver glycogen helps support circulating glucose.

What is glycogenolysis?

It is the breakdown of glycogen into glucose-related molecules.

What is lipolysis?

It is the breakdown of stored triglycerides into fatty acids and glycerol.

Does lipolysis prove body-fat loss?

No. Released fatty acids may be oxidised or returned to storage.

What is beta-oxidation?

It is the mitochondrial pathway that breaks fatty acids into acetyl-CoA-related units.

What is lactate?

Lactate is a normal metabolic intermediate that can be transported and reused as fuel or as a precursor.

Does lactate cause delayed muscle soreness?

No. Delayed soreness involves different tissue, immune, sensory, and pain-processing mechanisms.

What are ketones?

Ketones are liver-produced fuel molecules formed from fatty-acid-derived substrates under selected metabolic conditions.

Does ketosis mean the body has stopped using glucose?

No. Some tissues and pathways continue to require glucose.

Is ketosis the same as ketoacidosis?

No. Ketoacidosis is a dangerous acid-base disorder and is not equivalent to ordinary physiological ketosis.

Does a ketone reading prove body-fat loss?

No. Ketones do not reveal total energy balance or the complete source of the fatty acids used.

Can the brain use fat directly?

The brain does not rely substantially on circulating long-chain fatty acids as a direct fuel under ordinary conditions, but it can use ketone bodies during selected states.

Can the brain use ketones exclusively?

No. Some glucose requirement remains even when ketone use increases.

Where does protein fit into fuel use?

Amino acids are mainly used for structural and functional purposes but can contribute to gluconeogenesis and energy pathways.

Does the body burn muscle during fasting?

Protein turnover and amino-acid use may change during fasting, but the degree depends on fasting duration, body composition, activity, health, and other factors.

What is gluconeogenesis?

It is the production of glucose from non-carbohydrate precursors such as lactate, glycerol, and selected amino-acid-derived molecules.

Does gluconeogenesis create energy?

No. It uses energy to rearrange existing substrates into glucose-related molecules.

Why does exercise intensity affect fuel use?

Higher intensity requires faster ATP regeneration, increasing reliance on phosphocreatine, glycogen, and glycolysis.

Does low-intensity exercise burn more fat?

It may use a greater percentage of fat, but total energy use and total fat oxidation may differ from higher-intensity activity.

Does high-intensity exercise use no fat?

No. Fat oxidation may continue even when carbohydrate contribution is high.

Does exercise after fasting guarantee greater fat loss?

No. Acute fuel use does not independently determine long-term body composition or safety.

How does training change fuel use?

Training may alter mitochondria, enzymes, capillaries, glycogen storage, fatty-acid transport, and movement efficiency.

Does insulin control all fuel switching?

No. Glucagon, catecholamines, cortisol, substrate availability, cellular demand, and tissue-specific pathways also contribute.

Does insulin stop fat burning completely?

No. It generally suppresses fatty-acid release, but fat metabolism continues in several forms.

What does glucagon do?

It helps regulate liver glucose production, glycogen breakdown, amino-acid metabolism, and ketone-related pathways.

Does cortisol always increase blood glucose?

Its effects depend on timing, concentration, duration, health, other hormones, and metabolic context.

Can sleep affect fuel switching?

Yes. Sleep interacts with glucose regulation, appetite, cortisol rhythms, activity, and circadian timing.

Can stress change fuel use?

Stress-related hormones may alter glucose availability, lipolysis, appetite, sleep, and physical activity.

Does ageing reduce the ability to switch fuels?

Age-related changes may affect activity, muscle, mitochondria, sleep, hormones, and medications, but the response varies widely.

Can diabetes affect fuel switching?

Yes. Insulin availability, insulin responsiveness, liver glucose output, fat release, ketone production, and medicines may all be involved.

Can fuel switching be judged from hunger or fatigue?

No. These sensations are non-specific and cannot identify tissue-specific substrate use.

Can a smartwatch show whether the body is burning fat?

No. Most wearables estimate movement, heart rate, or energy expenditure rather than direct substrate oxidation.

What is respiratory exchange ratio?

It compares carbon-dioxide production with oxygen consumption and may help estimate whole-body fuel use under selected conditions.

Does respiratory exchange ratio show fuel use in every tissue?

No. It is a whole-body measurement and cannot reveal every tissue or cellular pathway.

Can blood fatty-acid levels show how much fat is being burned?

No. Blood concentration reflects the balance among release, uptake, storage, and oxidation.

Do peptides automatically improve fuel switching?

No. Mechanistic or preclinical findings do not establish safe human effects on fat oxidation, glucose use, fasting, weight loss, or metabolic flexibility.

Do BPC-157 studies establish fat-burning effects?

No. Laboratory or animal findings do not establish human fuel-switching, fat-loss, glucose-control, safety, dosing, or medical benefits.

Do TB-500 or thymosin-related studies establish metabolic effects?

No. Preclinical findings do not provide a complete human fuel-metabolism, safety, dosing, or effectiveness profile.

Does NAD+ automatically improve metabolic flexibility?

No. NAD+ participates in energy metabolism, but this does not establish that a specific product improves human fuel switching or causes fat loss.

Can buccal delivery improve fat oxidation?

No. Buccal delivery describes an administration route and does not establish metabolic, mitochondrial, glucose, ketone, or body-composition effects.

Can blood detection prove that a compound changed mitochondrial fuel use?

No. Blood exposure, tissue distribution, cellular entry, mitochondrial entry, target engagement, and metabolic change are separate stages.

Why are evidence limits important?

They prevent cell findings, animal studies, ketone readings, blood metabolites, short fasting studies, or exercise measurements from being overstated as proof of weight loss, metabolic correction, safety, or product effectiveness.

Research-Use Reminder

InStrips products are offered for research and analytical use only. Human consumption and medical application fall outside this product context. Changes in glucose, fatty acids, lactate, ketones, respiratory measurements, insulin-related signaling, blood concentration, or mitochondrial pathways do not independently establish diagnosis, safety, effectiveness, dosage, weight loss, improved metabolic flexibility, diabetes treatment, exercise enhancement, or suitability for human use.